Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.

The U.S. Food and Drug Administration has declined to approve Aldeyra Therapeutics' treatment for dry eye disease, the ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Danish biotech Gubra (CPSE: GUBRA) saw its share gains more than 8% to 448.00 kroner, after it announced positive results ...

Well, some North Dakota state lawmakers are test-driving a new concept: “If it is broke, pretend it’s not.” And the inattention could soon result in local businesses and working families spending even ...

The FDA’s confidence in the quality of America’s generic drug supply is contradicted by its enforcement actions. For example: Cipla received an FDA warning letter in November 2023 following ...

UKAD further affirmed that the athlete offered no other explanation for the failed drug test ... result,” read part of a UKAD statement. “In response, UKAD was provided with a doctor’s ...

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” fourth quarter 2024 investor letter. A copy of ... the release of Phase III results of its Cagri-Sema ...

The drug is suspected of being behind ... the only wastewater analysis that has published results on nitazenes was conducted ...

CRL focused on CMC; no clinical issues relating to etripamil raised. $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024 . MONTREAL and CHARLOTTE, ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Valisure is testing 40 medications to assess drug quality as part of a pilot study. Light said the tariffs could financially squeeze generic manufacturers, which might result in more cost-cutting.